143 related articles for article (PubMed ID: 29535023)
1. E7 oncoprotein of human papillomavirus: Structural dynamics and inhibitor screening study.
Aarthy M; Kumar D; Giri R; Singh SK
Gene; 2018 Jun; 658():159-177. PubMed ID: 29535023
[TBL] [Abstract][Full Text] [Related]
2. Modeling and molecular dynamics of the intrinsically disordered e7 proteins from high- and low-risk types of human papillomavirus.
Nicolau N; Giuliatti S
J Mol Model; 2013 Sep; 19(9):4025-37. PubMed ID: 23864166
[TBL] [Abstract][Full Text] [Related]
3. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
[TBL] [Abstract][Full Text] [Related]
4. Structural dynamic studies on identification of EGCG analogues for the inhibition of Human Papillomavirus E7.
Aarthy M; Panwar U; Singh SK
Sci Rep; 2020 May; 10(1):8661. PubMed ID: 32457393
[TBL] [Abstract][Full Text] [Related]
5. Structural investigation on the intrinsically disordered N-terminal region of HPV16 E7 protein.
Lee C; Kim DH; Lee SH; Su J; Han KH
BMB Rep; 2016 Aug; 49(8):431-6. PubMed ID: 27418281
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the binding of the human papillomavirus type 16 and cottontail rabbit papillomavirus E7 proteins to the retinoblastoma gene product.
Haskell KM; Vuocolo GA; Defeo-Jones D; Jones RE; Ivey-Hoyle M
J Gen Virol; 1993 Jan; 74 ( Pt 1)():115-9. PubMed ID: 8380832
[TBL] [Abstract][Full Text] [Related]
7. Protein intrinsic disorder and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs.
Uversky VN; Roman A; Oldfield CJ; Dunker AK
J Proteome Res; 2006 Aug; 5(8):1829-42. PubMed ID: 16889404
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for recognition of the tumor suppressor protein PTPN14 by the oncoprotein E7 of human papillomavirus.
Yun HY; Kim MW; Lee HS; Kim W; Shin JH; Kim H; Shin HC; Park H; Oh BH; Kim WK; Bae KH; Lee SC; Lee EW; Ku B; Kim SJ
PLoS Biol; 2019 Jul; 17(7):e3000367. PubMed ID: 31323018
[TBL] [Abstract][Full Text] [Related]
9. Predicted alpha-helix/beta-sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7.
Ullman CG; Haris PI; Galloway DA; Emery VC; Perkins SJ
Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):229-39. PubMed ID: 8870673
[TBL] [Abstract][Full Text] [Related]
10. Cysteine-rich positions outside the structural zinc motif of human papillomavirus E7 provide conformational modulation and suggest functional redox roles.
Chemes LB; Camporeale G; Sánchez IE; de Prat-Gay G; Alonso LG
Biochemistry; 2014 Mar; 53(10):1680-96. PubMed ID: 24559112
[TBL] [Abstract][Full Text] [Related]
11. The human papillomavirus-16 E7 oncoprotein exerts antiapoptotic effects via its physical interaction with the actin-binding protein gelsolin.
Mileo AM; Abbruzzese C; Vico C; Bellacchio E; Matarrese P; Ascione B; Federico A; Della Bianca S; Mattarocci S; Malorni W; Paggi MG
Carcinogenesis; 2013 Oct; 34(10):2424-33. PubMed ID: 23729654
[TBL] [Abstract][Full Text] [Related]
12. 3-(2-Chloropropyl amide)-4-methoxy-N-phenylbenzamide inhibits expression of HPV oncogenes in human cervical cancer cell.
Han F; Li Y; Lu Q; Ma L; Wang H; Jiang J; Li Z; Li Y
Virol J; 2017 Jul; 14(1):145. PubMed ID: 28754129
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccine encoding HPV-16 E7 with mutation in L-Y-C-Y-E pRb-binding motif induces potent anti-tumor responses in mice.
Bahrami AA; Ghaemi A; Tabarraei A; Sajadian A; Gorji A; Soleimanjahi H
J Virol Methods; 2014 Sep; 206():12-8. PubMed ID: 24880067
[TBL] [Abstract][Full Text] [Related]
14. Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7.
Maher DM; Bell MC; O'Donnell EA; Gupta BK; Jaggi M; Chauhan SC
Mol Carcinog; 2011 Jan; 50(1):47-57. PubMed ID: 21061268
[TBL] [Abstract][Full Text] [Related]
15. Kinetic recognition of the retinoblastoma tumor suppressor by a specific protein target.
Chemes LB; Sánchez IE; de Prat-Gay G
J Mol Biol; 2011 Sep; 412(2):267-84. PubMed ID: 21787785
[TBL] [Abstract][Full Text] [Related]
16. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
He L; Zhang E; Shi J; Li X; Zhou K; Zhang Q; Le AD; Tang X
Cancer Chemother Pharmacol; 2013 Mar; 71(3):713-25. PubMed ID: 23292117
[TBL] [Abstract][Full Text] [Related]
17. Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor.
Liu X; Clements A; Zhao K; Marmorstein R
J Biol Chem; 2006 Jan; 281(1):578-86. PubMed ID: 16249186
[TBL] [Abstract][Full Text] [Related]
18. Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes.
Jewers RJ; Hildebrandt P; Ludlow JW; Kell B; McCance DJ
J Virol; 1992 Mar; 66(3):1329-35. PubMed ID: 1310752
[TBL] [Abstract][Full Text] [Related]
19. A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells.
Bertagnin C; Messa L; Pavan M; Celegato M; Sturlese M; Mercorelli B; Moro S; Loregian A
Cancer Lett; 2023 Sep; 571():216331. PubMed ID: 37532093
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7.
Ohlenschläger O; Seiboth T; Zengerling H; Briese L; Marchanka A; Ramachandran R; Baum M; Korbas M; Meyer-Klaucke W; Dürst M; Görlach M
Oncogene; 2006 Sep; 25(44):5953-9. PubMed ID: 16636661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
